However, since many sarcomas are TP53Wt but do not have amplified MDM2 (are MDM2Wt), it would be of interest to investigate if Nutlin-3a could potentiate the response of MDM2Wt/TP53Wt tumours to conventional chemotherapy. The gene discussed is MDM2; the disease is neoplasm.